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Abstract
Background: Neurogenic neuroprotection is a promising approach for treating patients with ischemic brain lesions.
Fastigial nucleus stimulation (FNS) has been shown to reduce the tissue damage resulting from focal cerebral ischemia in
the earlier studies. However, the mechanisms of neuroprotection induced by FNS remain unclear. MicroRNAs (miRNAs)
are a newly discovered group of non-coding small RNA molecules that negatively regulate target gene expression and
involved in the regulation of pathological process. To date, there is a lack of knowledge on the expression of miRNA in
response to FNS. Thus, we study the regulation of miRNAs in the rat ischemic brain by the neuroprotection effect of FNS.
Methods: In this study, we used an established focal cerebral ischemia/reperfusion (IR) model in rats. MiRNA expression
profile of rat ischemic cortex after 1 h of FNS were investigated using deep sequencing. Microarray was performed to
study the expression pattern of miRNAs. Functional annotation on the miRNA was carried out by bioinformatics analysis.
Results: Two thousand four hundred ninety three miRNAs were detected and found to be miRNAs or miRNA candidates
using deep sequencing technology. We found that the FNS-related miRNAs were differentially expressed
according microarray data. Bioinformatics analysis indicated that several differentially expressed miRNAs might be a
central node of neuroprotection-associated genetic networks and contribute to neuroprotection induced by FNS.
Conclusions: MiRNA acts as a novel regulator and contributes to FNS-induced neuroprotection. Our study provides a
better understanding of neuroprotection induced by FNS.
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Background
Ischemic stroke is one of the leading causes of death and
disabilities globally and the options of therapeutic inter-
vention remained remarkably limited [1–3]. Fastigial nu-
cleus stimulation (FNS) provides long-lasting protection
against ischemic infarction, which is emerging as one of
promising approaches for treating patients with ischemic
brain lesions [4]. The fastigial nucleus (FN) is located at
the top of the fourth ventricle and includes adrenergic
intrinsic neurons and nerve fibers [5]. Fibers passing
through the FN can be excited by electrical stimulation,
leading to a series of reactions including reflexive vascu-
lar expansion, elevated blood pressure and increased
cerebral blood flow [6, 7]. Its biological function is far
more complicated than what we know. Based on the
previous study results made by us and other researchers,
a 1-h electrical stimulation of the FN reduces the vol-
ume of focal ischemic infarction produced by occluding
the middle cerebral artery (MCAO) in rats [4, 8]. The
area of salvage is confined to the ischemic penumbra.
This protection persisted for 10 but disappeared by 30 d
[6, 9]. Important data in the last two decades have dem-
onstrated that the neuroprotection initiated by stimula-
tion of FN is involving multiple mechanisms, including
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the inhibition of inflammatory response, excitotoxic
damage as well as apoptosis [10–13]. Although the ef-
fects of experimental FNS have been well established,
the mechanisms underlying this neurogenic neuropro-
tection remain a topic of intense investigation.
MicroRNAs (miRNAs), a large family of ~22 nucleo-
tide (nt) single-stranded non-coding small RNAs, are
derived from ~70 nt long stem-loop precursors (pre-
miRNAs) [14, 15]. They are found in various species of
animals, plants and viruses. miRNAs regulate the ex-
pression of target gene by promoting mRNA degradation
or inhibiting translation at the post-transcriptional [16].
Specific miRNAs have been reported to play important
roles in a wide range of physiological and pathological
processes [17–20]. Recently, studies have suggested
that miRNA may be an inducible factor to response
on the neuroprotection of ischemic pre-conditioning
(IPC) through their function in regulating gene ex-
pression [21, 22]. To date, however, whether FN
stimulation exerts its effect through miRNAs regula-
tion mechanisms remains unclear.
Thus, in this study, we investigated the miRNA pro-
files after FNS and associated neuroprotective mecha-
nisms for the first time. Our study would provide a basis
for further unravelling the mechanism on how miRNAs
directly responsible for FN stimulation, and its relevance




Male Sprague-Dawley rats (280–300 g) were purchased
from the Animal Experiment Center of Guangxi Medical
University. Animals were handled according to the
guidelines of the Council for International Organization
of Medical Sciences on Animal Experimentation (World
Health Organization, Geneva, Switzerland). The Guangxi
Medical University Animal Care and Use Committee ap-
proved the animal protocols.
Electrical stimulation of the FN and transient focal
cerebral ischemia
Rats were anesthetized with an intraperitoneal injec-
tion of 3.5 % chloral hydrate (1.0 ml/100 g, Sigma,
Missouri, USA). All efforts were made to minimize
suffering. The fastigial nucleus was accurately tar-
geted using a stereotaxic atlas of the rat brain. The
posterior border of bregma was set as the zero
point, and a hole (1.1 mm lateral, 11.1 mm posterior,
5.6 mm deep) was made for electrode attachment.
An YC-2 programmed electrical stimulation instru-
ment (Chengdu Instrument Factory, Chengdu, China)
was used to apply a 70-μA direct-current square-
wave pulse (50 Hz). Each electrical stimulation lasted
1 h.
An established focal cerebral ischemia/reperfusion (I/
R) model was employed 24 h later. Focal cerebral ische-
mia was induced in rats with the transient middle cere-
bral artery occlusion (MCAO) as previously described
[23]. A 0.285 mm diameter nylon monofilament suture
was used and the occlusion was maintained for 2 h. Rats
in the sham-operated group underwent only vascular
separation without filament insertion. Thereafter, the re-
perfusion was performed for various times (3 h, 6 h,
12 h, 24 h or 72 h).
RNA isolation
After 1 h of FNS in rats subjected to 2 h of MCAO
and various times (3 h, 6 h, 12 h, 24 h or 72 h) of
reperfusion, brain tissue sections (approximately
2 mm thick) from the point behind the optic chiasm
in the ipsilateral cortex were quickly dissected and
harvested on ice. Total RNA was extracted using Tri-
zol reagent (Invitrogen, California, USA) following the
manufacturer’s procedure. The quantity and purity of
total RNA were monitored via analysis by NanoDrop
ND-2000 spectrophotometer (Nano Drop, Delaware,
USA) at 260/280 nm (ratio 1.8–2.0). The integrity
was analyzed using a Bioanalyzer 2100 and RNA 6000
Nano Lab Chip Kit (Agilent, California, USA) with
RIN number >7.0.
Small RNA library preparation and sequencing
Approximately 1 μg of total RNA were used to pre-
pare small RNA library according to protocol of
TruSeq Small RNA Sample Prep Kit (Illumina, San
Diego, USA). Briefly, RNA molecules were ligated to
5’ and 3’ adaptors sequentially and converted to
cDNA by reverse transcription followed by PCR
amplification. The amplification products (around
140 bp) were excised from a 6 % polyacrylamide Tri-
borate-EDTA gel. The purified cDNA library was
used for cluster generation on Illumina’s Cluster Sta-
tion, and single-end sequencing (36 bp) was per-
formed on an Illumina Hiseq 2500 at the LC-BIO
(Hangzhou, China) following the manufacturer’s in-
structions for instrument use. Raw sequencing reads
were obtained using Illumina’s Sequencing Control
Studio software version 2.8 (SCS v2.8) following
real-time sequencing image analysis and base-calling
by Illumina’s Real-Time Analysis version 1.8.70
(RTAv1.8.70).
Standard small RNA analysis
A proprietary pipelinescript, ACGT101-miR v4.2 (LC
Sciences, Houston, Texas, USA), was used for sequen-
cing data analysis. Following the removal of adapter
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sequences, low-quality reads and common RNA families
(rRNA, tRNA, snRNA, snoRNA), unique sequences of
18–26 bases were mapped to Rattus norvegicus precur-
sors in miRBase 20.0 using a BLAST search to identify
known miRNAs and novel 3p- and 5p- derived miRNAs.
The unique sequences mapping to Rattus norvegicus
mature miRNAs in hairpin arms were identified as
known miRNAs. The unique sequences mapping to the
other arm of known Rattus norvegicus precursor hairpin
opposite to the annotated mature miRNA-containing
arm were considered to be novel 5p- or 3p- derived
miRNA candidates. The remaining sequences were
mapped to other mammals’ precursors in miRBase using
further BLAST searches. The unmapped sequences were
analyzed to predict potential novel miRNAs. A BLAST
search was performed against the Rattus norvegicus gen-
ome, and the sequences that contain hairpin RNA struc-
tures were predicted from the flanking 80-nt sequences
using RNAfold software (http://rna.tbi.univie.ac.at/cgi-
bin/RNAfold.cgi).
Microarray analysis
The miRNA microarray assays were performed by a ser-
vice provider (LC Sciences, Houston, USA). The cus-
tomμparaflo™ microfluidic chip contained 728 unique
miRNAs listed in Sanger miRBase release 20.0 and 479
predicted miRNA sequences detected from our sequen-
cing results. 5 μg total RNA was fractioned with a YM-
100 Microcon centrifugal filter (Millipore, Billerica,
USA) and the mall RNAs (<300 nt) isolated were 3’-ex-
tended with a poly (A) tail by poly (A) polymeras. Anoli-
gonucleotide tag was then ligated to the poly (A) tail for
laterfluorescent dye staining. Hybridization was performed
on a μParaflo™ microfluidic chip with 100 μl 6 × SSPE buf-
fer containing 25 % formamide at 34 °C overnight using a
micro-circulation pump (Atactic Technologies, Houston,
TX, USA). After hybridization, fluorescence labeling
using tag-specific Cy5 dyes was used for detection.
Hybridization images were collected by using a laser
scanner (GenePix 4000B, Molecular Device, Sunnyvale,
CA, USA) and digitized by Array-Pro image analysis soft-
ware (Media Cybernetics, Bethesda, Maryland, USA). Data
were analyzed by subtracting the background and then
normalizing the signals using a LOWESS filter (Locally-
weighted Regression). For two-color experiments, the
ratio of the two sets of detected signals (log2-transformed
and balanced) and P-values of the t-test were calculated; a
P-value <0.01 was considered as differentially expressed.
Target prediction and gene ontology analysis
For miRNAs expressed in significant amounts, we used
the miRanda algorithm base (http://www.microrna.org/
microrna/home.do) and TargetScan (http://www.targets-
can.org/) to predict miRNA target genes. Finally, the
data predicted by both algorithms were combined and
the overlaps were calculated. The most abundant miR-
NAs targets were also annotated using Gene Ontology
(GO) categories (http://www.geneontology.org/) and the
Kyoto Encyclopedia of Genes and Genomes (KEGG)
(http://www.genome.jp/kegg/pathway.html).
Results
Analysis and annotation of sequencing data
A cDNA library of small RNAs was prepared from a
mixture of rat ischemic cortex tissue at 5 time
points (3 h, 6 h, 12 h, 24 h and 72 h) of reperfusion
after 1 h of FNS. A total of 7,705,444 raw sequences
of small RNAs were obtained using Solexa deep se-
quencing. Adapter sequences, junk and low-quality
reads were removed, and 5,570,313 clean reads
(72.3 %) of 18 and 26 bases in length were processed
for sequencing analysis (Fig. 1a). Of these reads, the
majority of the small RNAs were 20–24 nt in size,
with the predominant species being 22 nt in length,
which is typical size range for Dicer-processed prod-
ucts (Fig. 1b).
To identify the known miRNAs in rat after FNS,
the sequencing data were processed through Illumina’s
Genome Analyzer Pipeline and the ACGT-miR pro-
gram (Additional file 1: Figure S1). Certain RNA ref-
erence sequences including mRNA, rRNA, tRNA,
snRNA, snoRNA and Rfam (921,075 reads, 16.5 %)
were filtered from the mappable reads. The remaining
4,649,238 reads were subjected to advance bioinfor-
matics analysis (Fig. 1c).
Among the clean reads, total 2,679,016 reads (Group
1 a) that represent 620 unique sequences were mapped
to known Rattus norvegicus pre-miRNAs and mature
miRNAs. In addition, 132,480 reads (Group 1b) repre-
sent 112 unique sequences mapped to other known
mammalian pre-miRNAs and miRNAs, but novel to
Rattus norvegicus. The above two group we identified
as known miRNAs.
According to the standard criteria for novel miRNA
identification, extended sequences at the aligned gen-
ome locations have a propensity to form hairpin
structures. 9813 reads (Group 2a) represent 42 unique
sequences mapped to known pre-miRNAs and gen-
ome; with the extended sequences at the mapped po-
sitions of the genome potentially form hairpins. They
are considered to be novel 5p- or 3p- derived miRNA
candidates. 69,370 reads (Group 4a) represent 781
unique sequences unmapped to known miRNAs but
mapped to genome and the hairpin RNA structures
containing sequences were predicated from the flank
80 nt sequences using RNAfold software. This part is
identified as novel miRNAs in rat. Known and pre-
dicted miRNAs are summarized in Table 1.
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The most abundantly expressed known miRNAs
In high-throughput sequencing, the expression level
of a unique miRNA can be measured by the fre-
quency of its read count. Among the 2493 unique
miRNAs, the frequency of various miRNAs varied
drastically, with high-copy (counts > 10,000) of the
frequent sequences taking up 22, whereas 1791 miR-
NAs were sequenced with five or fewer read counts.
To assess the expression of known miRNAs after 1 h
of FNS in focal ischemic rat brain, we analyzed all
620 mappable known miRNAs in the dataset. Their
counts ranged from 1 to 94,525 sequence reads. The
top 20 of most highly expressed known miRNAs are
listed in Table 2.
MiRNAs regulate expression of specific gene via
hybridization to mRNA transcripts to promote RNA
degradation, inhibit translation or both. To better
understand the biological functions of the most abun-
dant miRNAs involved in FNS, putative target genes
were predicted using by targetscan and miranda. The
Fig. 1 Generation and analysis of sequenced small RNAs from rat ischemic cortex tissue after FN stimulation. a Distribution of 7,705,444 raw
sequences obtained using Solexa deep sequencing. b Length distribution of sequenced small RNA. c Categorical distribution of 5,570,313
mappable reads
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target genes of top 20 abundant miRNAs were pre-
dicted. In total, 14,947 annotated mRNA transcripts
were predicted. To further understand the biological
significance of this abundant miRNAs, predicted tar-
gets of GO terms and KEGG pathway were intro-
duced. The putative target genes of abundant
miRNAs appeared to be involved in a broad range of
biological processes. Many signaling pathways were
found to be involved, including Metabolic pathway,
MAPK signaling pathway, Calcium signaling pathway,
Neurotrophin signaling pathway, VEGF signaling path-
way and apoptosis (Additional file 2: Table S1).
MiRNA expression patterns after FNS in the ischemic
cortex
Given the low percentage of counts for the low-copy
groups and the need for replicates due to their
higher possibility of sequencing errors, we designed a
Table 1 Known and predicted miRNAs
Group Unique miRs
Known miRs
Of specific species Group 1a 620
Of selected species, but novel to specific species Group 1b 112
Predicted miRs
Mapped to known pre-miRs of selected species and genome; within hairpins Group 2a 42
Mapped to known pre-miRs of selected species and genome; no hairpins Group 2b 374
Mapped to known pre-miRs and miRs of selected species but unmapped to genome Group 3a 197
Mapped to known pre-miRs of selected species but unmapped to genome Group 3b 561
Unmapped to known miRs but mapped to genome and within hairpins Group 4a 781
Overall (Unique miRNAs) 2493
Specific species: Rattus norvegicus; Specific species: Mammalia
Table 2 Top 20 of the most abundantly expressed miRNAs
miR_name miR_seq len Copy of the miRNA
rno-miR-125b–5p TCCCTGAGACCCTAACTTGTGA 22 94,525
rno–miR–219a–2–3p AGAATTGTGGCTGGACATCTGT 22 92,142
rno–miR–127–3p TCGGATCCGTCTGAGCTTGGCT 22 28,705
rno–let–7f–5p TGAGGTAGTAGATTGTATAGTT 22 18,363
rno–let–7i–5p TGAGGTAGTAGTTTGTGCTGTT 22 13,509
rno–miR–27b–3p TTCACAGTGGCTAAGTTCTGC 21 10,614
rno–let–7c–5p TGAGGTAGTAGGTTGTATGGTT 22 10,424
rno–miR–128–3p TCACAGTGAACCGGTCTCTTT 21 8521
rno–miR–379–5p TGGTAGACTATGGAACGTAGG 21 8379
rno–miR–181a–5p AACATTCAACGCTGTCGGTGAGT 23 8345
rno–miR–132–3p TAACAGTCTACAGCCATGGTCG 22 7192
rno–miR–29b–3p TAGCACCATTTGAAATCAGTGTT 23 6772
rno–let–7a–5p TGAGGTAGTAGGTTGTATAGTT 22 6511
rno–let–7b–5p TGAGGTAGTAGGTTGTGTGGTT 22 6388
rno–miR–218a–5p TTGTGCTTGATCTAACCATGT 21 6104
rno–miR–129–5p CTTTTTGCGGTCTGGGCTTGC 21 5216
rno–miR–434–3p TTTGAACCATCACTCGACTCCT 22 5113
rno–miR–99b–5p CACCCGTAGAACCGACCTTGCG 22 4921
rno–miR–25–3p CATTGCACTTGTCTCGGTCTGA 22 3456
rno–miR–148b–3p TCAGTGCATCACAGAACTTTGT 22 3332
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specific custom miRNA microarray chip excluding
low-copy sequences to analyze the miRNAs expres-
sion profiles. Following treatment with 1 h FNS or
non-FNS, rats were subjected to 2 h MCAO and
sacrificed at 3 h, 6 h, 12 h, 24 h or 72 h of reperfu-
sion respectively. RNA from the ischemic cortex was
collected to performed microarray analysis. 505 de-
tectable miRNA transcripts in the miRNA microar-
rays expressed at various time point, of which 414
miRNAs were detected at 3 h, 416 miRNAs were de-
tected at 6 h, 396 miRNAs were detected at 12 h,
388 miRNAs were detected at 24 h, 405 miRNAs
were detected at 72 h, and only 333 miRNAs were
detected in all groups (Fig. 2).
The expression profile of miRNAs provides a hint
of their potential functions. At 12 h time points, a
total of 24 miRNAs showed differential expression
with ∣log2∣ > 2, which was the most among the all
of time points (Additional file 3: Table S2). Of these
miRNAs, rno-miR-129-1-3p, rno-miR-153-3p, rno-
miR-29b-3p, rno-miR-29c-3p and rno-miR-451-5p
were down-regulated, whereas rno-let-7a-1-3p, rno-
miR-322-5p, rno-miR-3574 and rno-miR-628 were
observed to be highly upregulated with p < 0.01
(Fig. 3). These differentially expressed miRNAs may
play an important role in the protection after FNS.
Accordingly, target prediction of these 9 differen-
tially expressed miRNAs were performed. The target
genes predicted to be related to Calcium signaling
pathway, PPAR signaling pathway, TGF-beta signal-
ing pathway, Neurotrophin signaling pathway, MAPK
signaling pathway and so on (Fig. 4).
Fig. 3 Differentially expressed miRNAs at 12 h of reperfusion after
FNS. P < 0.01
Fig. 2 Differentially expressed miRNAs among five groups of different reperfusion time piont. Numbers presented the number of miRNAs
expressed in a group or overlapping between groups
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Discussion
FNS may offer a new approach to neuroprotection
against cerebral ischemia. FNS has been showed to
promote nerve tissue repair, reconstruction, neuro-
logical rehabilitation and improve stroke-related com-
plication [9, 10]. Nevertheless, the molecular mechanisms
that regulate gene expression during cerebral ische-
mia after FNS are still not completely understood.
Recently, increasing attention has been focused on
miRNAs, which are promising targets in the molecu-
lar mechanisms of gene regulation, pathology, and
drug actions [24, 25]. To date, the neural functional
relevance of such a central neural neuroprotective
network induced by FNS have yet to be revealed.
Our study presented the first profile of miRNA ex-
pression in the ischemic cortex after 1 h of FNS.
The differentially expressed miRNAs may participate
in neuroprotection induced by FNS, and provides
further insights into miRNAs functions in ischemic
injury.
In the present study, we used Solexa sequencing tech-
nology on small RNA libraries prepared from a mixture
sample of rat ischemic cortex at 5 time points (3, 6, 12,
24 and 72 h) of reperfusion after FNS. Total, 7,705,444
reads were detected, out of which 5,570,313 were clean
reads and represents 2493 unique tags. In all, 75.1 % of
Fig. 4 The top KEGG pathways of biological function of the targets of 9 differentially expressed miRNAs altered after FNS. The top 20 KEGG
pathways targeted by the up-regulated and the downregulated miRNAs were shown in the top and bottom panels, respectively. The vertical axis
was the pathway category and the horizontal axis was the –In(p-value) of pathway
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the mappable sequences were found to be miRNAs or
miRNA candidates. High throughput sequencing not
only has the ability to identify miRNAs, and to some ex-
tent reflects the gene expression information. The copy
numbers of miRNAs sequence in frequency response the
relative abundance of its expression. Among the se-
quenced sequences, the copy numbers of 117 miRNAs
greater than 10,000. We found that the most abundantly
expressed miRNAs are miR-125b-5p. miR-125b has been
described to be involved in different cellular processes
such as inflammation, cell proliferation, and cell cycle
regulation [26–29]. Other miRNAs that were abundantly
expressed after FNS include the let-7 family members.
Let-7 and its family members are highly conserved
across species in sequence [30, 31]. Despite their high
level of expression in the brain, the function in the cen-
tral nervous system is poorly addressed. The research
about these miRNAs will deepen our understanding of
the pathogenesis of neuroprotection induced by FNS.
To date, a total of 728 rat mature miRNAs were in-
cluded in the miRBase database (release 20) and
many rat miRNAs remain to be discovered. Given the
importance of rat as a model organism, discovery of
the completed set of rat miRNAs is necessary for un-
derstanding rat miRNA regulation. The identification
of FNS-related miRNAs by our deep sequencing ana-
lysis shows that the dataset is reliable not only for
characterizing expression profiles of known miRNAs
but also for discovery of novel miRNAs. However, we
are not able to determine how many miRNAs would
be missing in our study, because the sample for the
high-through sequencing was the mixed ischemic cor-
tex. We discovered a lot of potential novel miRNAs,
such as PC-5p-603_1535, PC-3p-3469_406, PC-5p-
3581_373, PC-5p-9723_139, ect. The identification of
novel miRNA has been expounded in another article
[32]. In this paper, we do not repeat narrative again.
Microarray data of miRNAs after FNS treatment in
ischemic rat cortex revealed significant changes in
several miRNAs. The differential expression profile of
miRNAs provides a hint of their potential functions
during neuroprotection. 9 miRNAs (rno-miR-129-1-
3p, rno-miR-153-3p, rno-miR-29b-3p, rno-miR-29c-3p,
rno-miR-451-5p, rno-let-7a-1-3p, rno-miR-322-5p,
rno-miR-3574 and rno-miR-628) showed statistically
significant change. MiRNAs are a class of sophisti-
cated gene expression regulators that inhibit transla-
tion and/or degrade target mRNAs by recognizing
them through base pairing with short regions near 3’-
UTRs. Hence, miRNAs can target various mRNAs
that could be part of a biological pathway. The puta-
tive target genes of differentially expressed miRNAs
appeared to be involved in Calcium signaling path-
way, PPAR signaling pathway, TGF-beta signaling
pathway, Neurotrophin signaling pathway, MAPK
signaling pathway and so on. PPARs act as nuclear
receptor and its activation induces a decrease in
neuronal death by prevention of oxidative or
inflammatory mechanisms implicated in cerebral in-
jury [33]. Neurotrophins are a family of trophic fac-
tors involved in differentiation and survival of neural
cells, which have now been shown to mediate both
positive and negative survival signals, by signalling
through the Trk and p75 neurotrophin receptors, re-
spectively [34, 35]. TGF-βs regulate a wide spectrum
of cellular functions such as proliferation, apoptosis,
differentiation and migration. TGF-beta signaling is a
molecular mechanism which limit neuroinflammation,
and activate TGF-beta in the peri-infarct cortex and
preserve brain function during the subacute period
after stroke [11, 36]. The MAP-kinase family mem-
bers are known to be stimulated after cerebral ische-
mia and were thought to regulate signal transduction,
gene expression and metabolism. Based on the above
information, we hypothesize that these differentially
expressed miRNAs serve as mediators of the brain’s
response to FNS that leads to endogenous neuropro-
tection. On the other hand, our research investigated
the role of miR-29c-3p in the neuroprotection in-
duced by FNS after ischemic injury and we found
that miR-29c-3p attenuated ischemic neuronal death
by negatively regulating apoptotic proteins Birc2 and
Bak1 associated with the PI3K-Akt signaling pathway
[37]. Our finding expand the understanding of miR-
NAs associated with ischemic cerebral disease and
may provide a basis for novel therapeutic strategies
aimed at enhancing tissue and cell survival in the is-
chemic stroke.
Conclusion
In conclusion, our study presented the first profile of
miRNA expression in the ischemic cortex after 1 h of
FNS. Several miRNAs exhibited significantly differential
expression. Bioinformatics analysis indicated that these
differentially expressed miRNAs may target various
mRNAs involved in biological pathway and act as en-
dogenous neuroprotection effectors. Next, we would
focus on elucidating the interactions and regulatory net-
works of specific miRNAs, which leading to endogenous
neuroprotection by in vivo experiments.
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